One patient discontinued therapy at his own request with subjective low response, although VAS-scores as well as blood values showed a positive trend.
← all excerpts
The value of biomarkers in the therapy of CRSwNP with biologicals-a long-term follow-up of dupilumab therapy.
1
—
—